1120
B. Wang et al. / Journal of Fluorine Chemistry 131 (2010) 1113–1121
4.2.1.4. (3-Cyanophenyl)(40-methoxyphenyl)-iodonium hexafluoro-
phosphate 6(PF6) (74%). [1H] NMR (CD3CN, 400 MHz, 25 8C):
4.2.3. Method C
d
In a glove box under N2, 1-(diacetoxyiodo)-4-bromobenzene
8.389 (t, J = 1.6 Hz, 1H, H-2), 8.273 (dd, J1 = 8.2 Hz, J2 = 1.6 Hz, 1H,
H-6), 8.038 (d, J = 9.4 Hz, 2H, H-20/H-60), 8.017 (dd, J1 = 8.2 Hz,
J2 = 1.6 Hz, 1H, H-4), 7.665 (t, J = 8.2 Hz, 1H, H-5), 7.082 (d, J = 9.4,
2H, H-30/H-50), 3.850 (s, 3H, 40-OMe); 13C NMR (CD3CN, 100 MHz,
(401 mg, 1 mmol) was weighed into a glass vial and dry
acetonitrile (3 mL) was added. A solution of p-toluenesulfonic
acid monohydrate (190 mg, 1 mmol) in 3 mL of dry acetonitrile
was added by syringe. Upon completion of the addition,
trimethylstannylbenzene (240 mg, 1 mmol) was added and the
vial was sealed, removed from the glove box, and the mixture was
allowed to stir at room temperature for 2 h. Water (20 mL) was
added and the mixture was transferred to a separatory funnel and
extracted (3ꢁ 5 mL) with hexanes. The reserved aqueous layer was
treated with NaPF6 (502 mg, 3 mmol). The white precipitate was
filtered, dried in vacuo, and recrystallized in a mixture of diethyl
ether/dichloromethane to give phenyl(4-bromophenyl)-iodonium
25 8C)
d
165.04 (C-40), 140.40 (C-6), 139.50 (C-2), 139.47 (C-20/C-
60), 137.79 (C-5), 134.13 (C-4), 119.75 (C-30/C-50), 117.63 (C-3),
116.75 (CN), 114.53 (C-1), 102.56 (C-10), 57.16 (40-OMe); 19F NMR
1
(CD3CN, 376 MHz, 25 8C)
d
ꢀ72.675 (d, JP–F = 707.5 Hz, PF6ꢀ);
HRMS (HRFAB): calcd. for C14H11NOI [MꢀPF6]+ 335.9885; found
335.9876.
4.2.1.5. (2,5-Dimethylphenyl)(40-methoxyphenyl)-iodonium hexa-
fluorophosphate 8(PF6) (62%). [1H] NMR (CD2Cl2, 400 MHz,
9(PF6) (400 mg, 75%). 1H NMR (CD3CN, 400 MHz, 25 8C):
d 8.076 (d,
25 8C):
d
7.88 (d, J = 9.1 Hz, H-20/H-60, 2H), 7.83 (s, H-6, 1H),
J = 7.6 Hz, 2H, H-20/H-60), 7.954 (d, J = 8.8 Hz, 2H, H-2/H-6), 7.740
(t, J = 7.6 Hz, 1H, H-40), 7.708 (d, J = 8.8 Hz, 2H, H-3/H-5), 7.562 (t,
7.41 (s, H-3/H-4, 2H), 7.03 (d, J = 9.1 Hz, H-30/H-50, 2H), 3.85 (s, 40-
OMe, 3H), 2.59 (s, 2-Me, 3H), 2.37 (s, 5-Me, 3H); 13C NMR (CD2Cl2,
100 MHz, 25 8C)
J = 7.6 Hz, 2H, H-30/H-50); 13C NMR (CD3CN, 100 MHz, 25 8C)
d
d
164.2 (C-40), 141.7 (C-2), 138.5 (C-5), 137.8 (C-20/
138.07 (C-2/C-6), 136.60 (C-3/C-5), 136.54 (C-20/C-60), 134.35 (C-
C-60), 137.1 (C-6), 135.4 (C-4), 132.6 (C-3), 119.4 (C-30/C-50), 118.0
(C-1), 98.7 (C-10), 56.5 (40-OMe), 25.3 (2-Me), 20.9 (5-Me); HRMS
(HRFAB): calcd. for C15H16OI [MꢀPF6]+ 339.0246, 340.0279; found
339.0239, 340.0277.
40), 133.68 (C-30/C-50), 128.89 (C-4), 114.48 (C-10), 112.27 (C-1); 19F
1
NMR (CD3CN, 376 MHz, 25 8C)
d
ꢀ72.851 (d, JP–F = 706.0 Hz,
PF6ꢀ); HRMS (HRFAB): calcd. for C12H9BrI [MꢀPF6]+ 358.8932,
360.8912; found 358.8938, 360.8904.
4.2.2. Method B
4.3. Syntheses of diaryliodonium triflates
In a glove box under N2, 1-(diacetoxyiodo)-4-methoxybenzene
(352 mg, 1 mmol) was weighed into a glass vial and 1.5 mL of dry
acetonitrile was added. A solution of p-toluenesulfonic acid
monohydrate (190 mg, 1 mmol) in 1.5 mL of dry acetonitrile
was added by syringe. Upon completion of the addition, 1 equiv. of
the appropriate tributylstannylarene (427 mg for 2, 442 mg for 7)
was added and the vial was sealed and taken out of the glove box.
The mixture was allowed to stir at room temperature for 2 h. Water
(10 mL) was added and the mixture was transferred to a separatory
funnel and extracted (3ꢁ 5 mL) with hexanes. The reserved
aqueous layer was treated with 502 mg (3 mmol) of NaPF6. The
white precipitate was filtered, dried in vacuo, and recrystallized in
a mixture of diethyl ether/dichloromethane to give the purified
product.
4.3.1. Phenyl(4-methoxyphenyl)-iodonium triflate 1(OTf)
To a stirred suspension of diacetoxyiodobenzene (660 mg,
2.05 mmol) in 10 mL dry methylene chloride at 0 8C under N2,
triflic acid (0.36 mL, 4.10 mmol) was added dropwise via syringe.
The mixture was stirred at 0 8C for 5 min and then at room
temperature for 1 h. The resulting clear yellow solution was cooled
to 0 8C and anisole (0.25 mL, 2.30 mmol) was added dropwise via
syringe. The resulting blue colored solution was stirred at 0 8C for
5 min and then at room temperature for 30 min. The volatiles were
removed in vacuo to obtain a dark brown oil which was triturated
with diethyl ether. The solvent was removed in vacuo to obtain an
off white solid which was triturated with diethyl ether. The solid
was collected by filtration and washed with diethyl ether to yield
the product 1(OTf) as a colorless, fine powdery solid (651 mg,
4.2.2.1. (3,4-Dimethoxyphenyl)(40-methoxyphenyl)-iodonium hexa-
70.7%). 1H NMR (500 MHz, CD3CN, 25 8C):
d 8.042 (d, J = 8.5 Hz, 2H,
fluorophosphate 2(PF6) (72%). [1H] NMR (CD3CN, 400 MHz,
H-20/H-60), 8.017 (d, J = 9.1 Hz, 2H, H-2/H-6), 7.690 (t, J = 7.6 Hz,
1H, H-40), 7.524 (t, J = 8.0 Hz, 2H, H-30/H-50), 7.055 (d, J = 9.1 Hz, 2H,
25 8C):
d
7.986 (d, J = 9.1 Hz, 2H, H-20/H-60), 7.647 (dd,
J1 = 8.9 Hz, J2 = 2.2 Hz, 1H, H-6), 7.558 (d, J = 2.2 Hz, 1H, H-2),
7.049 (d, J = 9.1 Hz, 2H, H-30/H-50), 7.022 (d, J = 8.9 Hz, 1H, H-5),
3.845 (s, 3H, 3-OMe), 3.843 (s, 3H, 40-OMe), 3.834 (s, 3H, 4-OMe);
H-3/H-5), 3.835 (s, 3H, OMe). 13C NMR (125 MHz, CD3CN, 25 8C):
d
164.67 (C-4), 139.02 (C-2/C-6), 136.23 (C-20/C-60), 134.14 (C-40),
133.66 (C-30/C-50), 122.37 (q, JC–F = 320.9 Hz, CF3SO3ꢀ), 119.47 (C-
3/C-5), 115.49 (C-10), 102.80 (C-1), 57.06 (OMe). 19F NMR
13C NMR (CD3CN, 100 MHz, 25 8C)
d
164.58 (C-40), 154.62 (C-4),
152.50 (C-3), 138.49 (C-20/C-60), 130.65 (C-6), 119.38 (C-2),
119.13 (C-30/C-50), 115.52 (C-5), 103.37 (C-1), 102.64 (C-10), 57.49
(376 MHz, CD3CN, 25 8C):
d
ꢀ79.29 (s, CF3SO3ꢀ).
(3-OMe), 57.14 (40-OMe), 57.05 (4-OMe); 19F NMR (CD3CN,
4.3.2. Bis(4-methoxyphenyl)iodonium triflate 3(OTf)
1
376 MHz, 25 8C)
(HRFAB): calcd. for
371.0156.
d
ꢀ72.786 (d, JP–F = 705.8 Hz, PF6ꢀ); HRMS
In a flame-dried 25 mL Schlenk flask charged with N2, 1-
(diacetoxyiodo)-4-methoxybenzene (753.0 mg, 2.13 mmol) was
dissolved in 7 mL dry methylene chloride. With stirring, anisole
(0.93 mL, 8.52 mmol) was added by syringe. The solution was
cooled to ꢀ10 8C in a sodium chloride-ice bath. To this solution,
triflic acid (0.21 mL, 2.34 mmol) was added dropwise over the
course of 10 min by syringe. A deep blue color was immediately
observed upon addition. After addition, the solution was allowed
to warm slowly to room temperature overnight. The volatiles were
removed in vacuo to obtain a crude solid. The solid was redissolved
in methylene chloride and precipitated with a 10% solution of ether
in hexanes to yield bis(4-methoxyphenyl)iodonium triflate as a
colorless solid (729.6 mg, 69.5%). 1H NMR (400 MHz, CD3CN,
C
15H16O3I [MꢀPF6]+ 371.0144; found
4.2.2.2. (2-Methyl-4,5-dimethoxyphenyl)(40-methoxyphenyl)-iodo-
nium hexafluorophosphate 7(PF6) (75%). [1H] NMR (CD3CN,
400 MHz, 25 8C):
d
7.939 (d, J = 9.2 Hz, 2H, H-20/H-60), 7.593 (s,
1H, H-6), 7.055 (d, J = 9.2 Hz, 2H, H-30/H-50), 7.026 (s, 1H, H-5),
3.835 (s, 6H, 3/40-OMe), 3.828 (s, 3H, 4-OMe), 2.550 (s, 3H, 2-Me);
13C NMR (CD3CN, 100 MHz, 25 8C)
d
164.45 (C-40), 154.63 (C-4),
150.46 (C-5), 138.28 (C-20/C-60), 136.71 (C-2), 120.59 (C-6),
119.41 (C-30/C-50), 115.28 (C-3), 107.01 (C-1), 102.58 (C-10), 57.51
(3-OMe), 57.14 (40-OMe), 57.04 (4-OMe); 19F NMR (CD3CN,
1
376 MHz, 25 8C)
(HRFAB): calcd. for
385.0313.
d
ꢀ72.735 (d, JP–F = 706.9 Hz, PF6ꢀ); HRMS
25 8C):
J = 8.8 Hz, 2H, H-3/H-30/H-5/H-50), 3.829 (s, 3H, OMe). 13C NMR
(100 MHz, CD3CN, 25 ?C):
164.258 (C-4/C-40), 138.280 (C-2/C-20/
d
7.981 (d, J = 8.8 Hz, 2H, H-2/H-20/H-6/H-60), 7.038 (d,
C
16H18O3I [MꢀPF6]+ 385.0301; found
d